Cargando…

Changes in Uterine Cancer Incidence Rates in Egypt

BACKGROUND: Uterine cancer is one of the top-ranking cancers in women with wide international variations in incidence rates. Developed countries have higher incidence rates than the developing countries. Egypt has significantly lower incidence of uterine cancer than other countries in the Middle Eas...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshahrani, Saad, Soliman, Amr S., Hablas, Ahmed, Ramadan, Mohamed, Meza, Jane L., Remmenga, Steven, Seifeldein, Ibrahim A., Chamberlain, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022259/
https://www.ncbi.nlm.nih.gov/pubmed/30013598
http://dx.doi.org/10.1155/2018/3632067
_version_ 1783335642344718336
author Alshahrani, Saad
Soliman, Amr S.
Hablas, Ahmed
Ramadan, Mohamed
Meza, Jane L.
Remmenga, Steven
Seifeldein, Ibrahim A.
Chamberlain, Robert M.
author_facet Alshahrani, Saad
Soliman, Amr S.
Hablas, Ahmed
Ramadan, Mohamed
Meza, Jane L.
Remmenga, Steven
Seifeldein, Ibrahim A.
Chamberlain, Robert M.
author_sort Alshahrani, Saad
collection PubMed
description BACKGROUND: Uterine cancer is one of the top-ranking cancers in women with wide international variations in incidence rates. Developed countries have higher incidence rates than the developing countries. Egypt has significantly lower incidence of uterine cancer than other countries in the Middle East. This study aimed at verifying the incidence rate of uterine cancer and characterizing the demographic and clinical profiles of patients residing in the Gharbiah province in the Nile delta region of Egypt. METHODS: Data from 660 uterine cancer patients diagnosed during the period of 1999 to 2010 were abstracted from the Gharbiah Cancer Registry, the only population-based registry in Egypt. The data included age, marital status, number of children, residence, smoking, occupation, date and basis of diagnosis, tumor topography, morphology, stage and grade, and treatment. Crude rate, age-standardized rate (ASR), and age-specific rate were calculated and associated with demographic and clinical characteristics of patients. RESULTS: The study confirmed the low ASR of uterine cancer in Egypt, (4.1 per 100,000 (95% CI: 3.8–4.4)). The incidence rate increased significantly over the 12-year period. The crude rate (CR) was 1.95, 95% CI (1.64–2.25) in 1999–2002; 2.9, 95% CI (2.5–3.2) in 2003–2006; and 3.5, 95% CI (3.1–3.9) in 2007–2010. The rate ratio was 1.5, 95% CI (1.2–1.8) in 2003–2006 and 1.8, 95% CI (1.5–2.2) in 2007–2010 compared to 1999–2002. The majority of patients (83%) were postmenopausal with the highest age-specific rate in the 60–69-year age group (22.07 per 100,000 (95% CI: 19.3–25.2). The majority of patients were diagnosed at early stages (60% localized and 5% regional), had adenocarcinoma (68%), and resided in urban areas (54%). CONCLUSIONS: The study confirmed the low incidence rate of uterine cancer in the Gharbiah province of Egypt and significant increase in incidence in recent years. Future studies should focus on verifying the possible effect of hysterectomy on lowering the incidence, the factors related to the changes in rates between rural and urban areas, and the possible impact of nutritional and epidemiologic transitions on the increasing rates.
format Online
Article
Text
id pubmed-6022259
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60222592018-07-16 Changes in Uterine Cancer Incidence Rates in Egypt Alshahrani, Saad Soliman, Amr S. Hablas, Ahmed Ramadan, Mohamed Meza, Jane L. Remmenga, Steven Seifeldein, Ibrahim A. Chamberlain, Robert M. Obstet Gynecol Int Research Article BACKGROUND: Uterine cancer is one of the top-ranking cancers in women with wide international variations in incidence rates. Developed countries have higher incidence rates than the developing countries. Egypt has significantly lower incidence of uterine cancer than other countries in the Middle East. This study aimed at verifying the incidence rate of uterine cancer and characterizing the demographic and clinical profiles of patients residing in the Gharbiah province in the Nile delta region of Egypt. METHODS: Data from 660 uterine cancer patients diagnosed during the period of 1999 to 2010 were abstracted from the Gharbiah Cancer Registry, the only population-based registry in Egypt. The data included age, marital status, number of children, residence, smoking, occupation, date and basis of diagnosis, tumor topography, morphology, stage and grade, and treatment. Crude rate, age-standardized rate (ASR), and age-specific rate were calculated and associated with demographic and clinical characteristics of patients. RESULTS: The study confirmed the low ASR of uterine cancer in Egypt, (4.1 per 100,000 (95% CI: 3.8–4.4)). The incidence rate increased significantly over the 12-year period. The crude rate (CR) was 1.95, 95% CI (1.64–2.25) in 1999–2002; 2.9, 95% CI (2.5–3.2) in 2003–2006; and 3.5, 95% CI (3.1–3.9) in 2007–2010. The rate ratio was 1.5, 95% CI (1.2–1.8) in 2003–2006 and 1.8, 95% CI (1.5–2.2) in 2007–2010 compared to 1999–2002. The majority of patients (83%) were postmenopausal with the highest age-specific rate in the 60–69-year age group (22.07 per 100,000 (95% CI: 19.3–25.2). The majority of patients were diagnosed at early stages (60% localized and 5% regional), had adenocarcinoma (68%), and resided in urban areas (54%). CONCLUSIONS: The study confirmed the low incidence rate of uterine cancer in the Gharbiah province of Egypt and significant increase in incidence in recent years. Future studies should focus on verifying the possible effect of hysterectomy on lowering the incidence, the factors related to the changes in rates between rural and urban areas, and the possible impact of nutritional and epidemiologic transitions on the increasing rates. Hindawi 2018-06-14 /pmc/articles/PMC6022259/ /pubmed/30013598 http://dx.doi.org/10.1155/2018/3632067 Text en Copyright © 2018 Saad Alshahrani et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Alshahrani, Saad
Soliman, Amr S.
Hablas, Ahmed
Ramadan, Mohamed
Meza, Jane L.
Remmenga, Steven
Seifeldein, Ibrahim A.
Chamberlain, Robert M.
Changes in Uterine Cancer Incidence Rates in Egypt
title Changes in Uterine Cancer Incidence Rates in Egypt
title_full Changes in Uterine Cancer Incidence Rates in Egypt
title_fullStr Changes in Uterine Cancer Incidence Rates in Egypt
title_full_unstemmed Changes in Uterine Cancer Incidence Rates in Egypt
title_short Changes in Uterine Cancer Incidence Rates in Egypt
title_sort changes in uterine cancer incidence rates in egypt
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022259/
https://www.ncbi.nlm.nih.gov/pubmed/30013598
http://dx.doi.org/10.1155/2018/3632067
work_keys_str_mv AT alshahranisaad changesinuterinecancerincidenceratesinegypt
AT solimanamrs changesinuterinecancerincidenceratesinegypt
AT hablasahmed changesinuterinecancerincidenceratesinegypt
AT ramadanmohamed changesinuterinecancerincidenceratesinegypt
AT mezajanel changesinuterinecancerincidenceratesinegypt
AT remmengasteven changesinuterinecancerincidenceratesinegypt
AT seifeldeinibrahima changesinuterinecancerincidenceratesinegypt
AT chamberlainrobertm changesinuterinecancerincidenceratesinegypt